Before Initiating Pharmaceutical Clinical Studies in China, a Meeting With the Center for Drug Evaluation (CDE) is a Must
In late October, the Chinese CDE outlined a strong recommendation for the review of clinical trials in China before they occur. In the past, the CDE mentioned the need for clinical trial sponsors to consult with them but recently, this recommendation has... Read More